|
positive regulation of t cell mediated cytotoxicity
|
GO:0001916 |
15 |
1.000
|
|
|
regulation of tolerance induction dependent upon immune response
|
GO:0002652 |
1 |
1.000
|
|
|
negative regulation of natural killer cell mediated immunity
|
GO:0002716 |
5 |
0.998
|
|
|
regulation of t cell mediated cytotoxicity
|
GO:0001914 |
18 |
0.997
|
|
|
antigen processing and presentation via mhc class ib
|
GO:0002475 |
8 |
0.996
|
|
|
positive regulation of leukocyte mediated cytotoxicity
|
GO:0001912 |
31 |
0.986
|
|
|
iron ion import into cell
|
GO:0097459 |
4 |
0.983
|
|
|
antigen processing and presentation of endogenous peptide antigen via mhc class i via er pathway
|
GO:0002484 |
3 |
0.983
|
|
|
antigen processing and presentation of endogenous peptide antigen via mhc class ib
|
GO:0002476 |
4 |
0.981
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.943
|
|
|
regulation of natural killer cell mediated immunity
|
GO:0002715 |
19 |
0.941
|
|
|
t cell mediated cytotoxicity
|
GO:0001913 |
26 |
0.929
|
|
|
positive regulation of tolerance induction dependent upon immune response
|
GO:0002654 |
1 |
0.916
|
|
|
antigen processing and presentation of peptide antigen via mhc class ib
|
GO:0002428 |
5 |
0.913
|
|
|
regulation of leukocyte mediated cytotoxicity
|
GO:0001910 |
38 |
0.898
|
|
|
natural killer cell mediated cytotoxicity
|
GO:0042267 |
29 |
0.894
|
|
|
regulation of cell killing
|
GO:0031341 |
40 |
0.889
|
|
|
positive regulation of t cell mediated immunity
|
GO:0002711 |
24 |
0.859
|
|
|
positive regulation of cell killing
|
GO:0031343 |
33 |
0.850
|
|
|
antigen processing and presentation of peptide antigen
|
GO:0048002 |
29 |
0.826
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.822
|
|
|
regulation of t cell mediated immunity
|
GO:0002709 |
34 |
0.821
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
62 |
0.767
|
|
|
antigen processing and presentation of endogenous peptide antigen via mhc class ib via er pathway tap dependent
|
GO:0002489 |
2 |
0.742
|
|
|
antigen processing and presentation of endogenous peptide antigen via mhc class i
|
GO:0019885 |
3 |
0.738
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.736
|
|
|
antigen processing and presentation of peptide antigen via mhc class i
|
GO:0002474 |
9 |
0.733
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.724
|
|
|
antigen processing and presentation
|
GO:0019882 |
47 |
0.723
|
|
|
antigen processing and presentation of exogenous peptide antigen via mhc class ib
|
GO:0002477 |
3 |
0.722
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.699
|
|
|
tolerance induction dependent upon immune response
|
GO:0002461 |
1 |
0.641
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.607
|
|
|
response to protozoan
|
GO:0001562 |
28 |
0.587
|
|
|
regulation of natural killer cell mediated cytotoxicity
|
GO:0042269 |
19 |
0.585
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.582
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.581
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.576
|
|
|
antigen processing and presentation of exogenous peptide antigen
|
GO:0002478 |
21 |
0.575
|
|
|
antigen processing and presentation of endogenous peptide antigen via mhc class i via er pathway tap dependent
|
GO:0002485 |
3 |
0.540
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.522
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.515
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.510
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.508
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.497
|
|
|
cell killing
|
GO:0001906 |
67 |
0.495
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.492
|
|
|
natural killer cell mediated immunity
|
GO:0002228 |
29 |
0.491
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.439
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.429
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.420
|
|
|
antigen processing and presentation of endogenous peptide antigen
|
GO:0002483 |
6 |
0.414
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.414
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.407
|
|
|
antigen processing and presentation of exogenous antigen
|
GO:0019884 |
26 |
0.406
|
|
|
positive regulation of lymphocyte mediated immunity
|
GO:0002708 |
62 |
0.395
|
|
|
cation transport
|
GO:0006812 |
399 |
0.393
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.391
|
|
|
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002822 |
87 |
0.386
|
|
|
antigen processing and presentation of endogenous antigen
|
GO:0019883 |
6 |
0.381
|
|
|
cellular response to interferon beta
|
GO:0035458 |
21 |
0.380
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.374
|
|
|
import into cell
|
GO:0098657 |
8 |
0.366
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.365
|
|
|
interferon gamma production
|
GO:0032609 |
67 |
0.364
|
|
|
positive regulation of innate immune response
|
GO:0045089 |
80 |
0.360
|
|
|
t cell activation involved in immune response
|
GO:0002286 |
43 |
0.356
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.346
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.345
|
|
|
interleukin 17 production
|
GO:0032620 |
11 |
0.321
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.310
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.304
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.297
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.296
|
|
|
negative regulation of innate immune response
|
GO:0045824 |
17 |
0.271
|
|
|
regulation of interferon gamma production
|
GO:0032649 |
57 |
0.270
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.259
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.259
|
|
|
positive regulation of tolerance induction
|
GO:0002645 |
8 |
0.251
|
|
|
antigen processing and presentation of endogenous peptide antigen via mhc class ib via er pathway
|
GO:0002488 |
2 |
0.244
|
|
|
ear development
|
GO:0043583 |
200 |
0.242
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.238
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.232
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.225
|
|
|
inorganic cation import into cell
|
GO:0098659 |
4 |
0.218
|
|
|
interleukin 1 production
|
GO:0032612 |
31 |
0.213
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.197
|
|
|
defense response to gram negative bacterium
|
GO:0050829 |
28 |
0.191
|
|
|
adhesion of symbiont to host
|
GO:0044406 |
8 |
0.190
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.188
|
|
|
positive regulation of natural killer cell mediated cytotoxicity
|
GO:0045954 |
16 |
0.187
|
|
|
multicellular organismal iron ion homeostasis
|
GO:0060586 |
8 |
0.181
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
11 |
0.172
|
|
|
t cell tolerance induction
|
GO:0002517 |
6 |
0.172
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.172
|
|
|
interleukin 1 beta production
|
GO:0032611 |
30 |
0.169
|
|
|
positive regulation of interferon gamma production
|
GO:0032729 |
39 |
0.158
|
|
|
cytokine production involved in immune response
|
GO:0002367 |
34 |
0.151
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.146
|
|
|
positive regulation of nitric oxide biosynthetic process
|
GO:0045429 |
14 |
0.142
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.136
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.135
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.133
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.131
|
|
|
alpha beta t cell activation involved in immune response
|
GO:0002287 |
31 |
0.126
|
|
|
positive regulation of natural killer cell mediated immunity
|
GO:0002717 |
16 |
0.121
|
|
|
antigen processing and presentation of exogenous protein antigen via mhc class ib tap dependent
|
GO:0002481 |
3 |
0.119
|
|
|
regulation of nitric oxide biosynthetic process
|
GO:0045428 |
18 |
0.117
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.112
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.111
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.109
|
|
|
antigen processing and presentation of exogenous peptide antigen via mhc class i
|
GO:0042590 |
6 |
0.108
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.106
|
|
|
cellular response to interferon gamma
|
GO:0071346 |
25 |
0.106
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.105
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.103
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.101
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.099
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.096
|
|
|
nitric oxide metabolic process
|
GO:0046209 |
25 |
0.096
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.095
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.094
|
|
|
negative regulation of lymphocyte mediated immunity
|
GO:0002707 |
21 |
0.093
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.093
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.092
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.087
|
|
|
regulation of type i interferon production
|
GO:0032479 |
22 |
0.082
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.082
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.081
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.080
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.079
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.079
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.077
|
|
|
negative regulation of leukocyte mediated immunity
|
GO:0002704 |
29 |
0.076
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.076
|
|
|
hormone biosynthetic process
|
GO:0042446 |
16 |
0.075
|
|
|
negative regulation of intracellular protein transport
|
GO:0090317 |
27 |
0.072
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.072
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.072
|
|
|
tolerance induction
|
GO:0002507 |
14 |
0.070
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.068
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.065
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.065
|
|
|
nitric oxide biosynthetic process
|
GO:0006809 |
25 |
0.063
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.063
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.063
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.062
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.062
|
|
|
regulation of myd88 independent toll like receptor signaling pathway
|
GO:0034127 |
1 |
0.061
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.060
|
|
|
response to interferon gamma
|
GO:0034341 |
34 |
0.060
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.060
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.059
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.058
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.056
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.055
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.055
|
|
|
negative regulation of natural killer cell mediated cytotoxicity
|
GO:0045953 |
5 |
0.054
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.053
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.053
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.053
|
|
|
defense response to protozoan
|
GO:0042832 |
25 |
0.052
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.051
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.051
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.050
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.050
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.050
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.049
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.048
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.047
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.047
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.047
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.047
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.046
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.046
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.045
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.045
|
|
|
response to interferon beta
|
GO:0035456 |
22 |
0.044
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.044
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.044
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.043
|
|
|
regulation of tolerance induction
|
GO:0002643 |
10 |
0.043
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
52 |
0.043
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.042
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.042
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.040
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.040
|
|
|
regulation of interferon alpha production
|
GO:0032647 |
5 |
0.040
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.039
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.039
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.038
|
|
|
negative regulation of defense response to virus by host
|
GO:0050689 |
1 |
0.038
|
|
|
protein refolding
|
GO:0042026 |
1 |
0.037
|
|
|
iron ion transport
|
GO:0006826 |
17 |
0.037
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.036
|
|
|
protein import
|
GO:0017038 |
101 |
0.036
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.035
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.034
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.034
|
|
|
viral life cycle
|
GO:0019058 |
36 |
0.033
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.032
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.032
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.031
|
|
|
neutrophil mediated killing of gram negative bacterium
|
GO:0070945 |
4 |
0.030
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.030
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.030
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.029
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.029
|
|
|
negative regulation of interferon beta biosynthetic process
|
GO:0045358 |
1 |
0.029
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.029
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.029
|
|
|
rna interference
|
GO:0016246 |
2 |
0.028
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.028
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.028
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.028
|
|
|
negative regulation of nucleocytoplasmic transport
|
GO:0046823 |
23 |
0.028
|
|
|
type i interferon production
|
GO:0032606 |
29 |
0.028
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.027
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.027
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.027
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.027
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.026
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.025
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.025
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.025
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.025
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.025
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.024
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.024
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.024
|
|
|
regulation of response to biotic stimulus
|
GO:0002831 |
38 |
0.023
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.023
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.023
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.022
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.022
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.021
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.021
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.021
|
|
|
inorganic ion import into cell
|
GO:0099587 |
4 |
0.021
|
|
|
ossification
|
GO:0001503 |
216 |
0.021
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.021
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.021
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.020
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.020
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.020
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.020
|
|
|
negative regulation of cell killing
|
GO:0031342 |
8 |
0.019
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.019
|
|
|
negative regulation of toll like receptor signaling pathway
|
GO:0034122 |
14 |
0.019
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.019
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.018
|
|
|
negative regulation of interferon alpha production
|
GO:0032687 |
1 |
0.018
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.018
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.018
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.018
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.018
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.018
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.018
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.017
|
|
|
regulation of defense response to virus
|
GO:0050688 |
18 |
0.017
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.017
|
|
|
syncytium formation by plasma membrane fusion
|
GO:0000768 |
42 |
0.017
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.017
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.017
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.017
|
|
|
lipopolysaccharide mediated signaling pathway
|
GO:0031663 |
25 |
0.017
|
|
|
regulation of defense response to fungus
|
GO:1900150 |
1 |
0.017
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.017
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.017
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.016
|
|
|
regulation of protein modification by small protein conjugation or removal
|
GO:1903320 |
57 |
0.016
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.016
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.016
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.016
|
|
|
regulation of autophagy
|
GO:0010506 |
30 |
0.016
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.016
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.016
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.015
|
|
|
cellular response to type i interferon
|
GO:0071357 |
10 |
0.015
|
|
|
regulation of cd8 positive alpha beta t cell activation
|
GO:2001185 |
3 |
0.015
|
|
|
response to drug
|
GO:0042493 |
75 |
0.015
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.015
|
|
|
positive regulation of interferon alpha production
|
GO:0032727 |
4 |
0.015
|
|
|
amide transport
|
GO:0042886 |
138 |
0.015
|
|
|
negative regulation of protein ubiquitination
|
GO:0031397 |
19 |
0.015
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.015
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.015
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.015
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.015
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.015
|
|
|
negative regulation of protein transport
|
GO:0051224 |
46 |
0.015
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.015
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.014
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.014
|
|
|
regulation of myoblast differentiation
|
GO:0045661 |
29 |
0.014
|
|
|
regulation of protein import into nucleus
|
GO:0042306 |
52 |
0.014
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.014
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.014
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.014
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.014
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.014
|
|
|
regulation of protein localization to nucleus
|
GO:1900180 |
60 |
0.014
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.013
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.013
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.013
|
|
|
posttranscriptional gene silencing
|
GO:0016441 |
10 |
0.013
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.013
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.013
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.013
|
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.013
|
|
|
regulation of neutrophil mediated killing of symbiont cell
|
GO:0070949 |
2 |
0.013
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.013
|
|
|
negative regulation of intracellular transport
|
GO:0032387 |
38 |
0.013
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.013
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.013
|
|
|
regulation of defense response to bacterium
|
GO:1900424 |
3 |
0.013
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.013
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.012
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.012
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.012
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.012
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.012
|
|
|
positive regulation of rig i signaling pathway
|
GO:1900246 |
1 |
0.012
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.012
|
|
|
negative regulation of cytoplasmic transport
|
GO:1903650 |
29 |
0.012
|
|
|
lysosomal transport
|
GO:0007041 |
10 |
0.012
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.012
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.012
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.012
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.012
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.012
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.012
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.012
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.012
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.012
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.012
|
|
|
activation of innate immune response
|
GO:0002218 |
56 |
0.012
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.011
|
|
|
positive regulation of antimicrobial humoral response
|
GO:0002760 |
2 |
0.011
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.011
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.011
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.011
|
|
|
disruption of cells of other organism involved in symbiotic interaction
|
GO:0051818 |
13 |
0.011
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.011
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.011
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.011
|
|
|
cd8 positive alpha beta t cell proliferation
|
GO:0035740 |
1 |
0.011
|
|
|
viral transcription
|
GO:0019083 |
3 |
0.011
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.011
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.011
|
|
|
autophagy
|
GO:0006914 |
45 |
0.011
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.011
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.011
|
|
|
innate immune response activating signal transduction
|
GO:0002758 |
50 |
0.011
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.011
|
|
|
regulation of viral transcription
|
GO:0046782 |
3 |
0.011
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.011
|
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.011
|
|
|
regulation of type i interferon mediated signaling pathway
|
GO:0060338 |
7 |
0.011
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.010
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.010
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.010
|
|
|
muscle fiber development
|
GO:0048747 |
76 |
0.010
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.010
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.010
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.010
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.010
|
|
|
histone modification
|
GO:0016570 |
159 |
0.010
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.010
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.010
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.010
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.010
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.010
|
|